Report Detail
Global Recombinant Human Serum Albumin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM2938908 |
- 26 September, 2024 |
- Global |
- 92 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins.
Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
According to our (Global Info Research) latest study, the global Recombinant Human Serum Albumin market size was valued at US$ 82.3 million in 2023 and is forecast to a readjusted size of USD 131 million by 2030 with a CAGR of 7.0% during review period.
Global key players of recombinant human serum albumin (Recombinant Human Serum Albumin) include Albumedix, Merck and Ventria (InVitria). The top three manufacturers account for about 88% of the global share. North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively. North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively. In terms of product type, ScrHSA is the largest segment, holding about 91% share. In terms of application, cell culture media is the largest downstream segment with about 73% share; followed by medical supplements.
This report is a detailed and comprehensive analysis for global Recombinant Human Serum Albumin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Recombinant Human Serum Albumin market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2019-2030
Global Recombinant Human Serum Albumin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2019-2030
Global Recombinant Human Serum Albumin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2019-2030
Global Recombinant Human Serum Albumin market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/g), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Human Serum Albumin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Human Serum Albumin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Human Serum Albumin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
OsrHSA
ScrHSA
Market segment by Application
Cell Culture Media
Medical Supplements
Other
Major players covered
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Serum Albumin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Serum Albumin, with price, sales quantity, revenue, and global market share of Recombinant Human Serum Albumin from 2019 to 2024.
Chapter 3, the Recombinant Human Serum Albumin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Serum Albumin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Recombinant Human Serum Albumin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Serum Albumin.
Chapter 14 and 15, to describe Recombinant Human Serum Albumin sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Recombinant Human Serum Albumin Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 OsrHSA
- 1.3.3 ScrHSA
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Recombinant Human Serum Albumin Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Cell Culture Media
- 1.4.3 Medical Supplements
- 1.4.4 Other
- 1.5 Global Recombinant Human Serum Albumin Market Size & Forecast
- 1.5.1 Global Recombinant Human Serum Albumin Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Recombinant Human Serum Albumin Sales Quantity (2019-2030)
- 1.5.3 Global Recombinant Human Serum Albumin Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Albumedix
- 2.1.1 Albumedix Details
- 2.1.2 Albumedix Major Business
- 2.1.3 Albumedix Recombinant Human Serum Albumin Product and Services
- 2.1.4 Albumedix Recombinant Human Serum Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Albumedix Recent Developments/Updates
- 2.2 Merck
- 2.2.1 Merck Details
- 2.2.2 Merck Major Business
- 2.2.3 Merck Recombinant Human Serum Albumin Product and Services
- 2.2.4 Merck Recombinant Human Serum Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Merck Recent Developments/Updates
- 2.3 Ventria (InVitria)
- 2.3.1 Ventria (InVitria) Details
- 2.3.2 Ventria (InVitria) Major Business
- 2.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Product and Services
- 2.3.4 Ventria (InVitria) Recombinant Human Serum Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Ventria (InVitria) Recent Developments/Updates
- 2.4 NCPC
- 2.4.1 NCPC Details
- 2.4.2 NCPC Major Business
- 2.4.3 NCPC Recombinant Human Serum Albumin Product and Services
- 2.4.4 NCPC Recombinant Human Serum Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 NCPC Recent Developments/Updates
- 2.5 Oryzogen
- 2.5.1 Oryzogen Details
- 2.5.2 Oryzogen Major Business
- 2.5.3 Oryzogen Recombinant Human Serum Albumin Product and Services
- 2.5.4 Oryzogen Recombinant Human Serum Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Oryzogen Recent Developments/Updates
- 2.6 HiMedia
- 2.6.1 HiMedia Details
- 2.6.2 HiMedia Major Business
- 2.6.3 HiMedia Recombinant Human Serum Albumin Product and Services
- 2.6.4 HiMedia Recombinant Human Serum Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 HiMedia Recent Developments/Updates
3 Competitive Environment: Recombinant Human Serum Albumin by Manufacturer
- 3.1 Global Recombinant Human Serum Albumin Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Recombinant Human Serum Albumin Revenue by Manufacturer (2019-2024)
- 3.3 Global Recombinant Human Serum Albumin Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Recombinant Human Serum Albumin by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Recombinant Human Serum Albumin Manufacturer Market Share in 2023
- 3.4.3 Top 6 Recombinant Human Serum Albumin Manufacturer Market Share in 2023
- 3.5 Recombinant Human Serum Albumin Market: Overall Company Footprint Analysis
- 3.5.1 Recombinant Human Serum Albumin Market: Region Footprint
- 3.5.2 Recombinant Human Serum Albumin Market: Company Product Type Footprint
- 3.5.3 Recombinant Human Serum Albumin Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Recombinant Human Serum Albumin Market Size by Region
- 4.1.1 Global Recombinant Human Serum Albumin Sales Quantity by Region (2019-2030)
- 4.1.2 Global Recombinant Human Serum Albumin Consumption Value by Region (2019-2030)
- 4.1.3 Global Recombinant Human Serum Albumin Average Price by Region (2019-2030)
- 4.2 North America Recombinant Human Serum Albumin Consumption Value (2019-2030)
- 4.3 Europe Recombinant Human Serum Albumin Consumption Value (2019-2030)
- 4.4 Asia-Pacific Recombinant Human Serum Albumin Consumption Value (2019-2030)
- 4.5 South America Recombinant Human Serum Albumin Consumption Value (2019-2030)
- 4.6 Middle East & Africa Recombinant Human Serum Albumin Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Recombinant Human Serum Albumin Sales Quantity by Type (2019-2030)
- 5.2 Global Recombinant Human Serum Albumin Consumption Value by Type (2019-2030)
- 5.3 Global Recombinant Human Serum Albumin Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Recombinant Human Serum Albumin Sales Quantity by Application (2019-2030)
- 6.2 Global Recombinant Human Serum Albumin Consumption Value by Application (2019-2030)
- 6.3 Global Recombinant Human Serum Albumin Average Price by Application (2019-2030)
7 North America
- 7.1 North America Recombinant Human Serum Albumin Sales Quantity by Type (2019-2030)
- 7.2 North America Recombinant Human Serum Albumin Sales Quantity by Application (2019-2030)
- 7.3 North America Recombinant Human Serum Albumin Market Size by Country
- 7.3.1 North America Recombinant Human Serum Albumin Sales Quantity by Country (2019-2030)
- 7.3.2 North America Recombinant Human Serum Albumin Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Recombinant Human Serum Albumin Sales Quantity by Type (2019-2030)
- 8.2 Europe Recombinant Human Serum Albumin Sales Quantity by Application (2019-2030)
- 8.3 Europe Recombinant Human Serum Albumin Market Size by Country
- 8.3.1 Europe Recombinant Human Serum Albumin Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Recombinant Human Serum Albumin Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Recombinant Human Serum Albumin Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Recombinant Human Serum Albumin Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Recombinant Human Serum Albumin Market Size by Region
- 9.3.1 Asia-Pacific Recombinant Human Serum Albumin Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Recombinant Human Serum Albumin Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Recombinant Human Serum Albumin Sales Quantity by Type (2019-2030)
- 10.2 South America Recombinant Human Serum Albumin Sales Quantity by Application (2019-2030)
- 10.3 South America Recombinant Human Serum Albumin Market Size by Country
- 10.3.1 South America Recombinant Human Serum Albumin Sales Quantity by Country (2019-2030)
- 10.3.2 South America Recombinant Human Serum Albumin Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Recombinant Human Serum Albumin Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Recombinant Human Serum Albumin Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Recombinant Human Serum Albumin Market Size by Country
- 11.3.1 Middle East & Africa Recombinant Human Serum Albumin Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Recombinant Human Serum Albumin Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Recombinant Human Serum Albumin Market Drivers
- 12.2 Recombinant Human Serum Albumin Market Restraints
- 12.3 Recombinant Human Serum Albumin Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Recombinant Human Serum Albumin and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Recombinant Human Serum Albumin
- 13.3 Recombinant Human Serum Albumin Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Recombinant Human Serum Albumin Typical Distributors
- 14.3 Recombinant Human Serum Albumin Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Recombinant Human Serum Albumin . Industry analysis & Market Report on Recombinant Human Serum Albumin is a syndicated market report, published as Global Recombinant Human Serum Albumin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Recombinant Human Serum Albumin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
